\(-ㅂ-)/♡ try Send-An-Email.com send anonymous email free

Clinical Experience: CDK4/6 Inhibitors in Breast Cancer

Say and pronounce Clinical Experience: CDK4/6 on SuperTTS.com Make Your Own Text-To-Speech Words Instantly

  Info

Description

Hope S. Rugo, MD, and Sara Hurvitz, MD, discuss the FDA approval of CDK4/6 inhibitors for metastatic hormone-driven breast cancer, the trials surrounding the approvals, and the indications for their use.

Tags

cancer oncology
  Email Video to Friends   Receive Emails for Similar Videos

Email:

  Repeat and Loop Video   Link to Video   Create Short URL  Publish Text About This Video   Share on Facebook, Twitter, and more
  See Recommended Videos For You
Old Cartoons on DVD. Visit and Bookmark: Cool90s.com!

Related

  Eric Vachon on the Effect of Complexity on Adherence with Kinase Inhibitors   First-Line Patient Selection for CDK Inhibitor Use   Breast cancer vaccine clinical trial making progress   Dr. Rugo on the Significance of the MONARCH I Trial for Breast Cancer   Dr. Pegram on Pertuzumab Plus Trastuzumab and Chemotherapy in Breast Cancer   Paula’s story: A team approach to battling breast cancer   Extended Aromatase Inhibitor Risk/Benefit   Researchers Develop New Method For Targeting Tumors   CDK4/6 Inhibitors: Managing Toxicity in HR+ mBC   CDK Inhibitors in Metastatic Hormone-Driven Breast Cancer   Research Shows Effective New Class Of Breast Cancer Drugs Well-Tolerated   The FDA Just Approved This New treatment For Metastatic Breast Cancers   Clinical Trials in Breast Cancer   Dr. Cardoso on the Global mBC Vision 2025 Call-to-Action   OSU Leads Clinical Trial For Aggressive Form Of Breast Cancer   CDK 4/6 Inhibitors in Metastatic Breast Cancer   Palbociclib and Breast Cancer   Dr. Higano on the Effectiveness of PARP Inhibitors for Prostate Cancer   Dr. Rugo on Extended Adjuvant Hormone Therapy for Breast Cancer   Novel Immunotherapy Combinations for NSCLC   Dr. Rugo on the Future of Extended Adjuvant Hormone Therapy for Breast Cancer   PI3K Inhibitors in HR+ Metastatic Breast Cancer   Upfront Use of Second-Line Agents in ALK+ NSCLC   CDK4/6 Inhibitors in Metastatic Breast Cancer   Dr. O’Shaughnessy on Differentiating Between CDK 4/6 Inhibitors   Patient Selection for Eribulin in Breast Cancer   Angie Meillier on Shared Decision Making in Breast Cancer   Dr. Esteva on the Clinical Implications of Genomic Testing for Breast Cancer   Evolving Therapeutic Landscape in Breast Cancer   Novartis Metastatic Breast Cancer Treatment   Dr. Freedman on Neratinib Plus Capecitabine for CNS Disease from HER2-Positive Breast Cancer   Cancer BRCA1 / BRCA2: Inherited mutations in these genes are the most common type of disease.   PI3K Inhibitors for HR+ Metastatic Breast Cancer   Dr. Mayer on Toxicities Associated With Therapies for ER+ Breast Cancer   Evolving Therapies in HR+ Metastatic Breast Cancer   FDA Approvals in Breast Cancer and Hodgkin Lymphoma, 2017 SGO Highlights, and More   Breast Thermography   Dr. Freedman on Preventing Brain Metastases in HER2+ Breast Cancer   Dr. Brufsky on the Disease-Free Survival of Aromatase Inhibitors for Breast Cancer   IT IS ABOUT TIME TO INDIVIDUALIZE CANCER TREATMENT | Dr. Michele Carpenter | TEDxCanonDriveWomen   Dr. Chagpar on Novel Agents for Neoadjuvant TNBC Treatment   FDA Approval in ALL, Priority Reviews in CML and Breast Cancer, and More   Clinical Hold Lifted in AML, and Encouraging Phase III Findings in Myeloma, CLL, and Breast Cancer   Study Finds HER2 Breast Cancer Driver In 3 Percent Of Lung Cancers   Dr. LoRusso on PARP Inhibitors in Triple-Negative Breast Cancer   JODHPUR: risk of breast cancer in males   Flaxseeds & Breast Cancer Survival: Clinical Evidence   What Are The Stages of Breast Cancer | Breast Cancer Stages   Adjuvant Hormonal Therapy for Estrogen Receptor Positive Early Stage Breast Cancer   Alarming rise in breast cancer cases in India: Learn these prevention tips   Breast cancer boutique opening soon   CDK4/6 Inhibitors in HR+ Metastatic Breast Cancer   Ongoing PARP Inhibitor Research in Ovarian Cancer   Proposed Clinical Trial Could Change Triple Negative Breast Cancer Treatment   Low-dose Aspirin May Reduce Breast Cancer Risk For Diabetic Women   STUDY: New Research Suggests Pregnancy After Cancer Does Not A Raise Risk of Recurrence   Proton Treatment for Breast Cancer   Making Strides Against Breast Cancer kickoff breakfast   Maintenance Strategies in Lung Cancer   San Diego woman: Stage zero cancer treatment deformed me   Important information women need to know about breast cancer. October is Breast Cancer Awareness Mon   Hoda Kotb Talks About Her Breast Cancer: ‘The World Snaps Into Focus’ | Megyn Kelly TODAY   Half of Breast Cancer Patients Experience Severe Side Effects   PARP Inhibitors for BRCA-Mutated TNBC   Dr. Verma Discusses Clinical Trial Endpoints in Metastatic Breast Cancer   Breast Cancer Awareness Month 10/12/16   Rini Explores PD-1 Inhibition in Renal Cell Carcinoma   Endocrine Resistance in HR+ Metastatic Breast Cancer   Living Healthy: Left Breast Cancer Treatment   ExteNET and NEfERTT Clinical Studies in Metastatic Breast Cancer   Woman with Stage IV Breast Cancer Speaks Out   Breast Cancer Treatment at Mayo Clinic   Young Woman Battles Breast Cancer - Jennifer's Story   Breast Cancer Treatment With Osteoporosis Drugs Makes Progress   New Microscope May Help Doctors Completely Remove Breast Cancer Tumors

Popular Today